GD2 targeting CAR T-cell therapy(University of Modena and Reggio Emilia)

N/A

Report date: 2024/04/09 16:59:30

Base Information

Drug NameGD2 targeting CAR T-cell therapy(University of Modena and Reggio Emilia)

Drug Alias NameN/A

ClassificationCell and gene therapy > Cell therapy > Immune system cell therapy > Lymphocytes therapy > T-lymphocyte cell therapy > Chimeric antigen receptor T cell therapy

Mechanisms of ActionDisialoganglioside GD2 modulators

TargetsDisialoganglioside GD2

Therapy Area/IndicationsGlioblastoma

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryItaly

CombinationsNo

Global Highest StatusPreclinical

Highest Status in ChinaN/A

Originator CompaniesUniversity Of Modena And Reggio Emilia

China Registration ClassN/A

Develop Information

Active CompaniesUniversity Of Modena And Reggio Emilia

Inactive CompaniesN/A

Active IndicationsGlioblastoma

Inactive IndicationsN/A

Other Information

ATC CodeN/A